Pharmacosmic: Journal of Pharmaceutical Sciences invites researchers, academicians, and industry professionals from around the world to contribute their valuable research and insights to our growing scientific community. We are committed to providing authors with a seamless, transparent, and efficient publication experience while maintaining the highest standards of scientific integrity.

Why Publish with Pharmacosmic

Global Visibility: Reach an international audience of pharmaceutical scientists, researchers, and industry professionals through our open-access platform and strategic indexing initiatives.

Rapid Publication: Experience efficient editorial processes with initial decisions typically provided within 4-6 weeks and final publication within 8-12 weeks of acceptance.

Rigorous Peer Review: Benefit from constructive feedback from internationally recognized experts in pharmaceutical sciences who are committed to advancing research quality and impact.

Open Access Advantage: Ensure maximum dissemination of your research through unrestricted access, increasing citation potential and research impact.

No Publication Fees: During our launch phase, we are waiving all article processing charges to support emerging researchers and institutions worldwide.

Professional Support: Access dedicated editorial assistance throughout the submission and review process, ensuring your research is presented in its best form.

Scope of Submissions

We welcome high-quality original research across all areas of pharmaceutical sciences, including but not limited to:

Core Pharmaceutical Sciences

• Pharmaceutics and drug formulation
• Pharmacokinetics and pharmacodynamics
• Biopharmaceutics and bioavailability studies
• Pharmaceutical analysis and quality control

Advanced Research Areas

• Novel drug delivery systems and nanotechnology
• Medicinal chemistry and drug design
• Pharmaceutical biotechnology and biologics
• Pharmacogenomics and personalized medicine
• Digital therapeutics and artificial intelligence applications
• Regulatory sciences and policy research

Clinical and Translational Research

• Clinical pharmacy and therapeutic drug monitoring
• Pharmacoepidemiology and outcomes research
• Drug safety and pharmacovigilance
• Translational pharmaceutical research

Types of Manuscripts

Original Research Articles (up to 8,000 words): Comprehensive reports of original investigations with significant contributions to pharmaceutical knowledge.

Review Articles (up to 10,000 words): Systematic reviews, meta-analyses, or comprehensive overviews of specific research areas.

Short Communications (up to 3,000 words): Brief reports of preliminary findings, novel methodologies, or significant technical advances.

Case Studies (up to 4,000 words): Detailed analyses of unique clinical cases, unusual drug reactions, or innovative therapeutic approaches.

Technical Notes (up to 2,500 words): Descriptions of new techniques, instrumentation, or methodological improvements.

Letters to the Editor (up to 1,000 words): Commentary on published articles, brief research notes, or professional opinions.

Submission Guidelines

Manuscript Preparation: All manuscripts must be prepared according to our detailed author guidelines, following international standards for scientific writing and citation.

Ethical Standards: All research must comply with relevant ethical guidelines, including appropriate institutional review board approvals and informed consent procedures.

Data Availability: Authors are encouraged to make research data available in appropriate repositories to support reproducibility and transparency.

Conflict of Interest: All potential conflicts of interest must be declared at the time of submission.

Language Support: While English is the primary language of publication, we provide language editing support for non-native speakers.

Review Process

Initial Editorial Assessment (1-2 weeks): Manuscripts undergo initial review for scope, significance, and technical quality.

Peer Review (3-4 weeks): Suitable manuscripts are sent to 2-3 expert reviewers for comprehensive evaluation.

Editorial Decision (1 week): Final decisions are made based on reviewer recommendations and editorial assessment.

Revision Process: Authors receive detailed feedback and are supported through the revision process to ensure publication success.

Post-Publication Services

Digital Object Identifier (DOI): All published articles receive permanent DOIs for reliable citation and tracking.

Indexing: We are actively pursuing indexing in major databases including Scopus, PubMed, and Web of Science.

Social Media Promotion: Published articles are promoted through our social media channels and professional networks.

Author Services: Continued support for reprint requests, citation tracking, and research impact metrics.